These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. Allen GC; Rosenberg H; Fletcher JE Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777 [TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update. Patil PM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956 [TBL] [Abstract][Full Text] [Related]
11. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil. Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345 [TBL] [Abstract][Full Text] [Related]
12. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824 [TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196 [TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia. Rosenberg H; Davis M; James D; Pollock N; Stowell K Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235 [TBL] [Abstract][Full Text] [Related]